Stay updated with breaking news from Pat whitworth. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ Prelude Corporation (PreludeDx®), a leader in precision diagnostics for early-stage breast cancer, announced the appointment of Dr. Pat. ....
Results show Black women had significantly higher rates of radiation therapy recommendation compared to White women with similar biosignature scores ....
/PRNewswire/ Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, announced today that. ....
/PRNewswire/ ImpediMed Limited (ASX: IPD) is pleased to announce publication of a systematic literature review showing that early detection and intervention. ....
New data suggest that existing restrictive criteria for germline genetic testing for breast cancer deny patients data-informed clinical management. ....